David E. Olson
David E. Olson is an American neuroscientist and chemist known for his research in the field of psychopharmacology. He is currently a faculty member at the University of California, Davis where he leads the Olson Lab, a research group focused on developing new treatments for neuropsychiatric disorders.
Early Life and Education
Olson was born and raised in the United States. He completed his undergraduate studies in chemistry and biology at the University of Wisconsin, Madison. He then pursued his doctoral degree in organic chemistry at Stanford University, where he studied under the guidance of Professor Barry Trost.
Career
After completing his Ph.D., Olson joined the Harvard Medical School as a postdoctoral fellow, where he worked in the laboratory of Professor Stuart Schreiber. He then moved to the University of California, Davis where he currently serves as an Assistant Professor in the Departments of Chemistry, Biochemistry, and Molecular Medicine.
At UC Davis, Olson leads the Olson Lab, a research group that focuses on the development of new treatments for neuropsychiatric disorders. His research primarily involves the use of psychedelic drugs to understand and treat various mental health conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD).
Research
Olson's research has been instrumental in understanding the potential therapeutic effects of psychedelic drugs. His work has shown that these substances can promote neuroplasticity, a process that allows the brain to change and adapt. This has significant implications for the treatment of neuropsychiatric disorders, as it suggests that psychedelic drugs could potentially be used to help rewire the brain and alleviate symptoms of these conditions.
Recognition
Olson's contributions to the field of psychopharmacology have been recognized with several awards and honors. He is a recipient of the National Institutes of Health (NIH) Director's New Innovator Award and the Brain & Behavior Research Foundation's NARSAD Young Investigator Grant.
See Also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD